Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BO7U
|
|||
| Drug Name |
BMX-001
|
|||
| Synonyms |
Bmx-001; UNII-MIJ02RO47F; MIJ02RO47F; Manganese(5+), ((2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl-kappaN21,kappaN22,kappaN23,kappaN24)tetrakis(1-(2-butoxyethyl)pyridiniumato))(2-))-, chloride (1:5), (sp-4-1)-; 1379783-91-1
Click to Show/Hide
|
|||
| Indication | Head and neck cancer [ICD-11: 2D42; ICD-9: 199] | Phase 2 | [1] | |
| Glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [2], [3] | ||
| Company |
BioMimetix Greenwood Village, CO
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C64H76Cl5MnN8O4
|
|||
| Canonical SMILES |
CCCCOCCN1C=CC=CC1=C2C3=NC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=CC=CC=[N+]7CCOCCCC)C8=CC=CC=[N+]8CCOCCCC)C=C4)C9=CC=CC=[N+]9CCOCCCC)C=C3.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3]
|
|||
| InChI |
1S/C64H76N8O4.5ClH.Mn/c1-5-9-41-73-45-37-69-33-17-13-21-57(69)61-49-25-27-51(65-49)62(58-22-14-18-34-70(58)38-46-74-42-10-6-2)53-29-31-55(67-53)64(60-24-16-20-36-72(60)40-48-76-44-12-8-4)56-32-30-54(68-56)63(52-28-26-50(61)66-52)59-23-15-19-35-71(59)39-47-75-43-11-7-3;;;;;;/h13-36H,5-12,37-48H2,1-4H3;5*1H;/q+2;;;;;;+3/p-5
|
|||
| InChIKey |
FVIXMTYHFFAYDY-UHFFFAOYSA-I
|
|||
| CAS Number |
CAS 1379783-91-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04607642) Trial of BMX-001 or Placebo in Head and Neck Cancer Patients. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.